This analysis revealed that both the “Xenobiotic metabolism” and “NFE2L2.V2” gene signatures are significantly upregulated upon G12Ci treatment (Fig. 1n), and thus confirms that activation of NRF2 is physiologically relevant and occurs in human cancer patients. This evidence concerns the gene NFE2L2 and cancer.